+

TNSN98194A1 - Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
TNSN98194A1
TNSN98194A1 TNTNSN98194A TNSN98194A TNSN98194A1 TN SN98194 A1 TNSN98194 A1 TN SN98194A1 TN TNSN98194 A TNTNSN98194 A TN TNSN98194A TN SN98194 A TNSN98194 A TN SN98194A TN SN98194 A1 TNSN98194 A1 TN SN98194A1
Authority
TN
Tunisia
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
methylerythromycin
derivatives
Prior art date
Application number
TNTNSN98194A
Other languages
English (en)
Inventor
Wu Yong-Jin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN98194A1 publication Critical patent/TNSN98194A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'INVENTION CONCERNE DES COMPOSES DE FORMULE I DANS LAQUELLE R1, R2, R3, R4 ET X REPRESENTENT DIVERS RADICAUX. ELLE CONCERNE EGALEMENT DES PROCEDES POUR LA PREPARATION DE CES COMPOSES, AINSI QUE DES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT. APPLICATION : UTILISATION DE CES COMPOSES ET COMPOSITIONS POUR LE TRAITEMENT OU LA PREVENTION D'INFECTIONS BACTERIENNES.
TNTNSN98194A 1997-10-29 1998-10-26 Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant TNSN98194A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6367697P 1997-10-29 1997-10-29

Publications (1)

Publication Number Publication Date
TNSN98194A1 true TNSN98194A1 (fr) 2005-03-15

Family

ID=22050768

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98194A TNSN98194A1 (fr) 1997-10-29 1998-10-26 Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (13)

Country Link
US (1) US6159945A (fr)
AP (1) AP9801378A0 (fr)
AR (1) AR017177A1 (fr)
AU (1) AU9277698A (fr)
CO (1) CO4810375A1 (fr)
GT (1) GT199800163A (fr)
HN (1) HN1998000159A (fr)
HR (1) HRP980571A2 (fr)
MA (1) MA26558A1 (fr)
PA (1) PA8461701A1 (fr)
PE (1) PE122499A1 (fr)
TN (1) TNSN98194A1 (fr)
WO (1) WO1999021866A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6248719B1 (en) 1998-06-03 2001-06-19 Pfizer Inc Tricyclic 3-keto derivatives of 6-O-methylerthromycin
ATE344269T1 (de) 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
EP1298138B1 (fr) * 1998-12-10 2006-11-02 Pfizer Products Inc. Dérivés anitiobiotiques de Carbamate et de Carbazate Kètolides
DE69913738T2 (de) 1999-01-27 2004-06-17 Pfizer Products Inc., Groton Ketolid-antibiotika
AU3832100A (en) * 1999-05-24 2000-12-12 Pfizer Products Inc. 13-methyl-erythromycin derivatives
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
US6498146B1 (en) * 1999-10-28 2002-12-24 Pfizer Inc Erythromycin derivatives
EP1146051A3 (fr) * 2000-04-10 2001-10-31 Pfizer Products Inc. Dérivées de l' érythromycine A
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
US20070185202A1 (en) * 2004-03-03 2007-08-09 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
CN101120011A (zh) 2004-12-21 2008-02-06 辉瑞产品公司 大环内酯
WO2009055557A1 (fr) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Procédé pour la préparation d'agents antibactériens macrolides
AU2009308180B2 (en) 2008-10-24 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating gastrointestinal diseases
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
US8975386B2 (en) 2010-03-22 2015-03-10 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
PL2571506T3 (pl) 2010-05-20 2017-10-31 Cempra Pharmaceuticals Inc Sposoby sporządzania makrolidów i ketolidów oraz ich produktów pośrednich
EP2613630A4 (fr) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc Fluorocétolides formant des liaisons hydrogène pour traiter les maladies
EP2830632A4 (fr) 2012-03-27 2015-10-21 Cempra Pharmaceuticals Inc Formulations parentérales pour l'administration d'antibiotiques macrolides
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
RU2015138797A (ru) 2013-03-15 2017-04-24 Семпра Фармасьютикалс, Инк. Конвергентные способы получения макролидных антибактериальных агентов
MX377459B (es) * 2013-04-04 2025-03-10 Harvard College Macrolidos y metodos para su preparacion y uso.
WO2016057798A1 (fr) 2014-10-08 2016-04-14 President And Fellows Of Harvard College Kétolides à 14 chaînons et leurs procédés de préparation et d'utilisation
US10640528B2 (en) 2015-03-25 2020-05-05 President And Fellows Of Havard College Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US6060234A (en) * 1991-01-17 2000-05-09 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
CA2118488C (fr) * 1992-04-22 2002-11-05 Toshifumi Asaka Derive du 5-o-desosaminylerythronolide a
AU6932098A (en) * 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
EP0988308A1 (fr) * 1997-06-11 2000-03-29 Pfizer Products Inc. Derives de 9-oxime erythromycine

Also Published As

Publication number Publication date
PA8461701A1 (es) 2000-05-24
PE122499A1 (es) 1999-12-02
AR017177A1 (es) 2001-08-22
WO1999021866A1 (fr) 1999-05-06
AP9801378A0 (en) 2000-04-29
CO4810375A1 (es) 1999-06-30
GT199800163A (es) 2000-04-15
HRP980571A2 (en) 1999-08-31
US6159945A (en) 2000-12-12
MA26558A1 (fr) 2004-12-20
HN1998000159A (es) 1999-02-09
AU9277698A (en) 1999-05-17

Similar Documents

Publication Publication Date Title
TNSN98194A1 (fr) Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98084A1 (fr) Derives de macrolides substitues en position c-4
TNSN98082A1 (fr) DERIVES SUBSTITUES EN C - 4 DE 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCINE A.
TNSN98238A1 (fr) Macrolides nouveaux
TNSN99236A1 (fr) Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99106A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99170A1 (fr) Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97198A1 (fr) Derives de 6-phenylpyridyl-2- amine et compositions pharmaceutiques les contenant
TNSN98203A1 (fr) Derives de thienopyrimidine et tienopyridine utiles comme agents anticancereux, et compositions les contenant
TNSN97110A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99169A1 (fr) Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99253A1 (fr) Composes chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
TNSN01091A1 (fr) Derives bicycliques nouveaux, compositions les contenant et leur utilisation pour le traitement d'une croissance cellulaire anormale
TNSN97145A1 (fr) Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00104A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99142A1 (fr) Derives de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procede pour leur preparation.
TNSN97144A1 (fr) Derives 6,6-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99205A1 (fr) Macrolides antibiotiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
TNSN98112A1 (fr) Composes dipeptidiques
TNSN00007A1 (fr) Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99155A1 (fr) 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98083A1 (fr) Derives de 6-0 methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98127A1 (fr) Derives d'azetidinylpropylpiperidine , procede pour leur preparation et compositions pharmaceutiques les contenant.
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载